FDA approves once-weekly Awiqli for children aged 10 and older with type 2 diabetes — sources for revision 1
U.S. Food and Drug Administration
Source date: 2026-10-23.
Supporting location: Action, Effectiveness and Safety Information.
Source dates are distinct from Iliyn’s preparation date. Source statements do not independently prove underlying events. No full source articles or source photographs are reproduced.